Percutaneous
breast biopsy is the gold standard for breast cancer diagnosis. Core Needle Biopsy (CNB) and Vacuum-Assisted Breast Biopsy (VABB) are the two most widely adopted minimally invasive techniques. Although both fall under percutaneous puncture procedures, they bear fundamental disparities in operating mechanisms, sampling efficiency and compatibility with image guidance.
1. Fundamental Differences in Operating Mechanisms
Conventional CNB adopts a spring-powered cutting assembly: after the needle tip reaches the target lesion, spring activation rapidly advances the inner stylet, followed by the outer cannula cutting tissue and trapping the specimen. A single puncture only retrieves one tissue core roughly 1–2 mm in diameter and 10–20 mm in length. Multiple needle insertions and withdrawals are required for multi-site sampling, aggravating tissue trauma and prolonging procedure time.
VABB integrates a built-in vacuum system. A Sample Notch is fabricated on the lateral wall of the needle. Once inserted into the lesion, negative vacuum pressure draws tissue into the notch, then a rotating or reciprocating Cutting Cannula severs the tissue and transports it to a collection chamber. Multiple specimens can be harvested consecutively with one needle placement without retraction. Needle gauges including 10G, 12G and 14G deliver larger tissue volumes, which are especially suitable for en bloc resection of microcalcification clusters or small lesions.
2. Compatibility with Image Guidance Modalities
CNB is mostly performed under ultrasound guidance and delivers reliable outcomes for ultrasound-visualized masses. However, its diagnostic accuracy declines for lesions manifested solely as clustered microcalcifications (requiring stereotactic biopsy) or occult lesions detected by MRI.
VABB is inherently compatible with multiple imaging modalities. Laser-etched markings (e.g., graduation lines on the Sample Notch Cannula) are radiopaque under X-ray and MRI. Vacuum suction stabilizes adhered tissue and minimizes target deviation induced by respiratory movement. At present, VABB is the only standard biopsy modality applicable interchangeably under ultrasound, stereotactic and MRI guidance.
3. Sampling Efficiency and Tissue Volume
Clinical studies demonstrate that VABB collects an average of 8–12 tissue cores per single needle insertion, with total specimen weight 3 to 5 times that of CNB. Sufficient tissue volume is critical for precision medicine assays including hormone receptor testing, HER2 amplification analysis and gene expression profiling. Moreover, VABB enables en bloc resection of suspicious microcalcifications to achieve "diagnostic excision", while CNB often suffers calcification loss due to specimen fragmentation.
4. Equipment Complexity and Cost
CNB features simple hardware; manual or semi-automatic biopsy guns come with low costs and a short operator learning curve. VABB requires dedicated vacuum pumps, collection canisters and control systems (e.g., BD's EnCor system), leading to high capital investment. Disposable compatible needles (such as those manufactured by Manners) also carry a high unit price.
Nevertheless, comprehensive health economic evaluations prove VABB offers superior cost-effectiveness for specific patient cohorts (e.g., BI-RADS 4A and above), as it reduces the incidence of repeat punctures and subsequent open surgical excision.
Conclusion
Technical mechanisms define clinical application scopes. CNB serves as the primary first-line screening tool thanks to its simplicity and speed. By contrast, VABB is irreplaceable for complex cases, microcalcifications and precise preoperative staging, supported by vacuum assistance, continuous sampling and multi-modality imaging compatibility. Selection between the two techniques should be determined by lesion characteristics, imaging accessibility and economic considerations, rather than a simple one-or-the-other replacement relationship.
